Table of Contents

Table of Contents

Preface

Editors Contact Information

Chapter 1 – High Prevalence of Uterine Fibroids in Women of Color (pp. 1-12)
Torie C. Plowden, MD, MPH, Monica N. Modi, MD, Lisa Green, MD, MPH and Alicia Y. Armstrong, MD, MHSCR (Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, US and others)

Chapter 2 – Somatic Stem Cells in Leiomyoma Formation (pp. 13-30)
Aymara Mas, PhD and Carlos Simón, MD, PhD (Fundación Instituto Valenciano de Infertilidad, Instituto Universitario IVI- University of Valencia, INCLIVA, Valencia, Spain and others)

Chapter 3 – Obesity, Inflammation and Fibroids (pp. 31-44)
Monica N. Modi, MD, Charles Armstrong and William H. Catherino, MD, PhD (Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan, US and others)

Chapter 4 – Uterine Fibroids and Endometrial Dysfunction (pp. 45-66)
Sara A. Mohamed, MD, Waseem Khoder, MD and Ayman Al-Hendy, MD, PhD (Department of Obstetrics and Gynecology, Faculty of Medicine, Mansoura University, Mansoura, Egypt and others)

Chapter 5 – Imaging of Leiomyoma (pp. 67-102)
Penelope L. Moyle, MBChB(hons), MRCP, FRCR, Amir Helmy, Bsc, MBBS, MRCS, and Susan Freeman, BA(hons), MB, BChir, MRCP, FRCR (Department of Radiology, Cambridge University Hospital NHS Trust, Cambridge, United Kingdom)

Chapter 6 – Etiology, Clinical Manifestations, Evaluation and Management of Uterine Leiomyoma (pp. 103-124)
Mohammad Ebrahim Parsanezhad, MD and Bahia Namavar Jahromi, MD (Infertility Research Center, Department of OB-GYN, Division of Reproductive endocrinology and infertility, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran)

Chapter 7 – Recent advances in Medical Treatment of Uterine Fibroids (pp. 125-150)
Heba M. Eltoukhi, MD and Ayman Al-Hendy, MD, PhD (Department of Obstetrics & Gynecology, Suez Canal University, Ismailia, Egypt and others)

Chapter 8 – Medical Adjuncts for the Surgical Management of Uterine Fibroids (pp. 151-174)
Innie Chen, MD, FRCSC, Catherine Allaire, Sukhbir S. Singh and George Vilos (Department of Obstetrics and Gynaecology, University of Ottawa; Department of Obstetrics and Gynaecology, University of British Columbia, and Department of Obstetrics and Gynaecology, Western University, Canada)

Chapter 9 – Radiofrequency Volumetric Thermal Ablation of Symptomatic Uterine Fibroids: The Acessa Procedure (pp. 175-192)
Bruce B. Lee, MD, Keith B. Isaacson, MD and Michael P. Diamond, MD (Halt Medical, Inc., Brentwood, California, US and others)
<a href=”https://novapublishers.com/wp-content/uploads/2019/03/978-1-63463-584-4_ch9.pdf” target=”_blank” rel=”noopener”>Free Download Available</a>

Chapter 10 – Treatment of Uterine Fibroids by Temporary Transvaginal Uterine Artery Occlusion: A Concept to Consider Further? (pp. 193-198)
Jay M. Berman, MD, Elizabeth Puscheck, MD., MS, Michelle Yoscovits, BS, Karen Collins, MA, MS, Roy Collins, RN, MD and Michael P. Diamond, MD (Division of Gynecology,
Wayne State University, Detroit, Michigan, US and others)

Chapter 11 – Looking for New Druggable Targets in Uterine Fibroids (pp. 199-208)
Shahinaz Shalaby, MD, MSc and Ayman Al-Hendy, MD, PhD (Pharmacology Department, Tanta Medical School, Tanta University, Tanta, Egypt and others)

Index